| Multistate point-prevalence survey of health care–associated infections SS Magill, JR Edwards, W Bamberg, ZG Beldavs, G Dumyati, MA Kainer, ... New England Journal of Medicine 370 (13), 1198-1208, 2014 | 4103 | 2014 |
| Burden of Clostridium difficile Infection in the United States FC Lessa, Y Mu, WM Bamberg, ZG Beldavs, GK Dumyati, JR Dunn, ... New England Journal of Medicine 372 (9), 825-834, 2015 | 2695 | 2015 |
| The natural history of hepatitis C virus infection: host, viral, and environmental factors DL Thomas, J Astemborski, RM Rai, FA Anania, M Schaeffer, N Galai, ... Jama 284 (4), 450-456, 2000 | 1450 | 2000 |
| Changes in prevalence of health care–associated infections in US hospitals SS Magill, E O’Leary, SJ Janelle, DL Thompson, G Dumyati, J Nadle, ... New England Journal of Medicine 379 (18), 1732-1744, 2018 | 1021 | 2018 |
| Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. Multistate point-prevalence survey of health care-associated infections SS Magill, JR Edwards, W Bamberg, ZG Beldavs, G Dumyati, MA Kainer, ... N Engl J Med 370 (13), 1198-1208, 2014 | 833 | 2014 |
| Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes AY Guh, Y Mu, LG Winston, H Johnston, D Olson, MM Farley, LE Wilson, ... New England Journal of Medicine 382 (14), 1320-1330, 2020 | 583 | 2020 |
| Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011 AS Chitnis, SM Holzbauer, RM Belflower, LG Winston, WM Bamberg, ... JAMA internal medicine 173 (14), 1359-1367, 2013 | 540 | 2013 |
| Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013 AY Guh, SN Bulens, Y Mu, JT Jacob, J Reno, J Scott, LE Wilson, E Vaeth, ... Jama 314 (14), 1479-1487, 2015 | 379 | 2015 |
| Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel—33 US sites, January–March 2021 T Pilishvili MMWR. Morbidity and mortality weekly report 70, 2021 | 224 | 2021 |
| Prospective study of infective endocarditis among injection drug users LE Wilson, DL Thomas, J Astemborski, TL Freedman, D Vlahov The Journal of infectious diseases 185 (12), 1761-1766, 2002 | 208 | 2002 |
| Clostridium difficile Infection Among Children Across Diverse US Geographic Locations JM Wendt, JA Cohen, Y Mu, GK Dumyati, JR Dunn, SM Holzbauer, ... Pediatrics 133 (4), 651-658, 2014 | 167 | 2014 |
| Progression of liver fibrosis among injection drug users with chronic hepatitis C LE Wilson, M Torbenson, J Astemborski, H Faruki, C Spoler, R Rai, ... Hepatology 43 (4), 788-795, 2006 | 132 | 2006 |
| Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort KA Gebo, MD Burkey, GM Lucas, RD Moore, LE Wilson JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (4), 426-432, 2006 | 124 | 2006 |
| Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile Infection CV Gould, JR Edwards, J Cohen, WM Bamberg, LA Clark, MM Farley, ... Clinical infectious diseases 57 (9), 1304-1307, 2013 | 114 | 2013 |
| Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals AH Greenbaum, LE Wilson, JC Keruly, RD Moore, KA Gebo Aids 22 (17), 2331-2339, 2008 | 111 | 2008 |
| Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study AY Guh, SH Adkins, Q Li, SN Bulens, MM Farley, Z Smith, SM Holzbauer, ... Open forum infectious diseases 4 (4), ofx171, 2017 | 101 | 2017 |
| Severity and correlates of liver disease in hepatitis C virus-infected injection drug users R Rai, LE Wilson, J Astemborski, F Anania, M Torbenson, C Spoler, ... Hepatology 35 (5), 1247-1255, 2002 | 95 | 2002 |
| Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection R Dantes, Y Mu, LA Hicks, J Cohen, W Bamberg, ZG Beldavs, G Dumyati, ... Open forum infectious diseases 2 (3), ofv113, 2015 | 84 | 2015 |
| Assessment of the appropriateness of antimicrobial use in US hospitals SS Magill, E O’Leary, SM Ray, MA Kainer, C Evans, WM Bamberg, ... JAMA Network Open 4 (3), e212007-e212007, 2021 | 80 | 2021 |
| Improved phenotype-based definition for identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae N Chea, SN Bulens, T Kongphet-Tran, R Lynfield, KM Shaw, PS Vagnone, ... Emerging infectious diseases 21 (9), 1611, 2015 | 74 | 2015 |
